 | • レポートコード：QYR9ST03970 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、膵臓癌治療の世界市場について調査・分析し、膵臓癌治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（生物学、化学療法、標的療法、その他）、用途別（病院、診療所、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の膵臓癌治療市場動向 ・主要企業別マーケットシェア ・膵臓癌治療の種類別市場規模2014-2019 （生物学、化学療法、標的療法、その他） ・膵臓癌治療の用途別市場規模2014-2019 （病院、診療所、その他） ・膵臓癌治療の北米市場：主要企業・種類別/用途別市場規模 ・膵臓癌治療のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・膵臓癌治療の中国市場：主要企業・種類別/用途別市場規模 ・膵臓癌治療の日本国内市場：主要企業・種類別/用途別市場規模 ・膵臓癌治療の東南アジア市場：主要企業・種類別/用途別市場規模 ・膵臓癌治療のインド市場：主要企業・種類別/用途別市場規模 ・膵臓癌治療の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Eli Lilly、Roche、Pfizer、Merck、Celgene、Novartis、Amgen、Teva Pharmaceutical、PharmaCyte Biotech、Clovis Oncology） ・膵臓癌治療の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Pancreatic cancer therapy is recommended by clinicians for early detection of cancer. Pancreatic cancer generally diagnosed at a later stage, since the symptoms are not easily detected or diagnosed. Factors such as, chronic inflammation of the pancreas (pancreatitis), diabetes, smoking, and obesity are some of the identified causes of pancreatic cancer.In May 2018, Eli Lilly and Company acquired AMRO BioSciences. AMRO BioSciences is engaged into number of drugs for cancer. The clinical trial explores a drug (pegilodecakin) which is ongoing for the pancreatic cancer. The drug is into phase III of the clinical trials. The acquisition will enhance the therapy products for the Eli Lilly and Company.
In 2018, the global Pancreatic Cancer Therapy market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Pancreatic Cancer Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Pancreatic Cancer Therapy development in United States, Europe and China.
The key players covered in this study
Eli Lilly
Roche
Pfizer
Merck
Celgene
Novartis
Amgen
Teva Pharmaceutical
PharmaCyte Biotech
Clovis Oncology
Market segment by Type, the product can be split into
Biology
Chemotherapy
Targeted Therapy
Others
Market segment by Application, split into
Hospitals
Clinics
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Pancreatic Cancer Therapy status, future forecast, growth opportunity, key market and key players.
To present the Pancreatic Cancer Therapy development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Pancreatic Cancer Therapy are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Pancreatic Cancer Therapy Market Size Growth Rate by Type (2014-2025)
1.4.2 Biology
1.4.3 Chemotherapy
1.4.4 Targeted Therapy
1.4.5 Others
1.5 Market by Application
1.5.1 Global Pancreatic Cancer Therapy Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Pancreatic Cancer Therapy Market Size
2.2 Pancreatic Cancer Therapy Growth Trends by Regions
2.2.1 Pancreatic Cancer Therapy Market Size by Regions (2014-2025)
2.2.2 Pancreatic Cancer Therapy Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Pancreatic Cancer Therapy Market Size by Manufacturers
3.1.1 Global Pancreatic Cancer Therapy Revenue by Manufacturers (2014-2019)
3.1.2 Global Pancreatic Cancer Therapy Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Pancreatic Cancer Therapy Market Concentration Ratio (CR5 and HHI)
3.2 Pancreatic Cancer Therapy Key Players Head office and Area Served
3.3 Key Players Pancreatic Cancer Therapy Product/Solution/Service
3.4 Date of Enter into Pancreatic Cancer Therapy Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Pancreatic Cancer Therapy Market Size by Type (2014-2019)
4.2 Global Pancreatic Cancer Therapy Market Size by Application (2014-2019)
5 United States
5.1 United States Pancreatic Cancer Therapy Market Size (2014-2019)
5.2 Pancreatic Cancer Therapy Key Players in United States
5.3 United States Pancreatic Cancer Therapy Market Size by Type
5.4 United States Pancreatic Cancer Therapy Market Size by Application
6 Europe
6.1 Europe Pancreatic Cancer Therapy Market Size (2014-2019)
6.2 Pancreatic Cancer Therapy Key Players in Europe
6.3 Europe Pancreatic Cancer Therapy Market Size by Type
6.4 Europe Pancreatic Cancer Therapy Market Size by Application
7 China
7.1 China Pancreatic Cancer Therapy Market Size (2014-2019)
7.2 Pancreatic Cancer Therapy Key Players in China
7.3 China Pancreatic Cancer Therapy Market Size by Type
7.4 China Pancreatic Cancer Therapy Market Size by Application
8 Japan
8.1 Japan Pancreatic Cancer Therapy Market Size (2014-2019)
8.2 Pancreatic Cancer Therapy Key Players in Japan
8.3 Japan Pancreatic Cancer Therapy Market Size by Type
8.4 Japan Pancreatic Cancer Therapy Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Pancreatic Cancer Therapy Market Size (2014-2019)
9.2 Pancreatic Cancer Therapy Key Players in Southeast Asia
9.3 Southeast Asia Pancreatic Cancer Therapy Market Size by Type
9.4 Southeast Asia Pancreatic Cancer Therapy Market Size by Application
10 India
10.1 India Pancreatic Cancer Therapy Market Size (2014-2019)
10.2 Pancreatic Cancer Therapy Key Players in India
10.3 India Pancreatic Cancer Therapy Market Size by Type
10.4 India Pancreatic Cancer Therapy Market Size by Application
11 Central & South America
11.1 Central & South America Pancreatic Cancer Therapy Market Size (2014-2019)
11.2 Pancreatic Cancer Therapy Key Players in Central & South America
11.3 Central & South America Pancreatic Cancer Therapy Market Size by Type
11.4 Central & South America Pancreatic Cancer Therapy Market Size by Application
12 International Players Profiles
12.1 Eli Lilly
12.1.1 Eli Lilly Company Details
12.1.2 Company Description and Business Overview
12.1.3 Pancreatic Cancer Therapy Introduction
12.1.4 Eli Lilly Revenue in Pancreatic Cancer Therapy Business (2014-2019)
12.1.5 Eli Lilly Recent Development
12.2 Roche
12.2.1 Roche Company Details
12.2.2 Company Description and Business Overview
12.2.3 Pancreatic Cancer Therapy Introduction
12.2.4 Roche Revenue in Pancreatic Cancer Therapy Business (2014-2019)
12.2.5 Roche Recent Development
12.3 Pfizer
12.3.1 Pfizer Company Details
12.3.2 Company Description and Business Overview
12.3.3 Pancreatic Cancer Therapy Introduction
12.3.4 Pfizer Revenue in Pancreatic Cancer Therapy Business (2014-2019)
12.3.5 Pfizer Recent Development
12.4 Merck
12.4.1 Merck Company Details
12.4.2 Company Description and Business Overview
12.4.3 Pancreatic Cancer Therapy Introduction
12.4.4 Merck Revenue in Pancreatic Cancer Therapy Business (2014-2019)
12.4.5 Merck Recent Development
12.5 Celgene
12.5.1 Celgene Company Details
12.5.2 Company Description and Business Overview
12.5.3 Pancreatic Cancer Therapy Introduction
12.5.4 Celgene Revenue in Pancreatic Cancer Therapy Business (2014-2019)
12.5.5 Celgene Recent Development
12.6 Novartis
12.6.1 Novartis Company Details
12.6.2 Company Description and Business Overview
12.6.3 Pancreatic Cancer Therapy Introduction
12.6.4 Novartis Revenue in Pancreatic Cancer Therapy Business (2014-2019)
12.6.5 Novartis Recent Development
12.7 Amgen
12.7.1 Amgen Company Details
12.7.2 Company Description and Business Overview
12.7.3 Pancreatic Cancer Therapy Introduction
12.7.4 Amgen Revenue in Pancreatic Cancer Therapy Business (2014-2019)
12.7.5 Amgen Recent Development
12.8 Teva Pharmaceutical
12.8.1 Teva Pharmaceutical Company Details
12.8.2 Company Description and Business Overview
12.8.3 Pancreatic Cancer Therapy Introduction
12.8.4 Teva Pharmaceutical Revenue in Pancreatic Cancer Therapy Business (2014-2019)
12.8.5 Teva Pharmaceutical Recent Development
12.9 PharmaCyte Biotech
12.9.1 PharmaCyte Biotech Company Details
12.9.2 Company Description and Business Overview
12.9.3 Pancreatic Cancer Therapy Introduction
12.9.4 PharmaCyte Biotech Revenue in Pancreatic Cancer Therapy Business (2014-2019)
12.9.5 PharmaCyte Biotech Recent Development
12.10 Clovis Oncology
12.10.1 Clovis Oncology Company Details
12.10.2 Company Description and Business Overview
12.10.3 Pancreatic Cancer Therapy Introduction
12.10.4 Clovis Oncology Revenue in Pancreatic Cancer Therapy Business (2014-2019)
12.10.5 Clovis Oncology Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Pancreatic Cancer Therapy Key Market Segments
Table Key Players Pancreatic Cancer Therapy Covered
Table Global Pancreatic Cancer Therapy Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Pancreatic Cancer Therapy Market Size Market Share by Type 2014-2025
Figure Biology Figures
Table Key Players of Biology
Figure Chemotherapy Figures
Table Key Players of Chemotherapy
Figure Targeted Therapy Figures
Table Key Players of Targeted Therapy
Figure Others Figures
Table Key Players of Others
Table Global Pancreatic Cancer Therapy Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Others Case Studies
Figure Pancreatic Cancer Therapy Report Years Considered
Table Global Pancreatic Cancer Therapy Market Size 2014-2025 (Million US$)
Figure Global Pancreatic Cancer Therapy Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Pancreatic Cancer Therapy Market Size by Regions 2014-2025 (Million US$)
Table Global Pancreatic Cancer Therapy Market Size by Regions 2014-2019 (Million US$)
Table Global Pancreatic Cancer Therapy Market Share by Regions 2014-2019
Figure Global Pancreatic Cancer Therapy Market Share by Regions 2014-2019
Figure Global Pancreatic Cancer Therapy Market Share by Regions 2019
Table Market Top Trends
Table Global Pancreatic Cancer Therapy Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Pancreatic Cancer Therapy Market Share by Manufacturers (2014-2019)
Figure Global Pancreatic Cancer Therapy Market Share by Manufacturers in 2018
Table Global Pancreatic Cancer Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Pancreatic Cancer Therapy Product/Solution/Service
Table Date of Enter into Pancreatic Cancer Therapy Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Pancreatic Cancer Therapy Market Size by Type (2014-2019) (Million US$)
Table Global Pancreatic Cancer Therapy Market Size Share by Type (2014-2019)
Figure Global Pancreatic Cancer Therapy Market Size Market Share by Type (2014-2019)
Table Global Pancreatic Cancer Therapy Market Size by Application (2014-2019) (Million US$)
Table Global Pancreatic Cancer Therapy Market Size Share by Application (2014-2019)
Figure Global Pancreatic Cancer Therapy Market Size Market Share by Application (2014-2019)
Figure Global Pancreatic Cancer Therapy Revenue Market Share by Application in 2018
Figure United States Pancreatic Cancer Therapy Market Size 2014-2019 (Million US$)
Table United States Key Players Pancreatic Cancer Therapy Revenue (2018-2019) (Million US$)
Table United States Key Players Pancreatic Cancer Therapy Market Share (2018-2019)
Table United States Pancreatic Cancer Therapy Market Size by Type (2014-2019) (Million US$)
Table United States Pancreatic Cancer Therapy Market Share by Type (2014-2019)
Table United States Pancreatic Cancer Therapy Market Size by Application (2014-2019) (Million US$)
Table United States Pancreatic Cancer Therapy Market Share by Application (2014-2019)
Figure Europe Pancreatic Cancer Therapy Market Size 2014-2019 (Million US$)
Table Europe Key Players Pancreatic Cancer Therapy Revenue (2018-2019) (Million US$)
Table Europe Key Players Pancreatic Cancer Therapy Market Share (2018-2019)
Table Europe Pancreatic Cancer Therapy Market Size by Type (2014-2019) (Million US$)
Table Europe Pancreatic Cancer Therapy Market Share by Type (2014-2019)
Table Europe Pancreatic Cancer Therapy Market Size by Application (2014-2019) (Million US$)
Table Europe Pancreatic Cancer Therapy Market Share by Application (2014-2019)
Figure China Pancreatic Cancer Therapy Market Size 2014-2019 (Million US$)
Table China Key Players Pancreatic Cancer Therapy Revenue (2018-2019) (Million US$)
Table China Key Players Pancreatic Cancer Therapy Market Share (2018-2019)
Table China Pancreatic Cancer Therapy Market Size by Type (2014-20189) (Million US$)
Table China Pancreatic Cancer Therapy Market Share by Type (2014-2019)
Table China Pancreatic Cancer Therapy Market Size by Application (2014-2019) (Million US$)
Table China Pancreatic Cancer Therapy Market Share by Application (2014-2019)
Figure Japan Pancreatic Cancer Therapy Market Size 2014-2019 (Million US$)
Table Japan Key Players Pancreatic Cancer Therapy Revenue (2018-2019) (Million US$)
Table Japan Key Players Pancreatic Cancer Therapy Market Share (2018-2019)
Table Japan Pancreatic Cancer Therapy Market Size by Type (2014-2019) (Million US$)
Table Japan Pancreatic Cancer Therapy Market Share by Type (2014-2019)
Table Japan Pancreatic Cancer Therapy Market Size by Application (2014-2019) (Million US$)
Table Japan Pancreatic Cancer Therapy Market Share by Application (2014-2019)
Figure Southeast Asia Pancreatic Cancer Therapy Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Pancreatic Cancer Therapy Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Pancreatic Cancer Therapy Market Share (2018-2019)
Table Southeast Asia Pancreatic Cancer Therapy Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Pancreatic Cancer Therapy Market Share by Type (2014-2019)
Table Southeast Asia Pancreatic Cancer Therapy Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Pancreatic Cancer Therapy Market Share by Application (2014-2019)
Figure India Pancreatic Cancer Therapy Market Size 2014-2019 (Million US$)
Table India Key Players Pancreatic Cancer Therapy Revenue (2018-2019) (Million US$)
Table India Key Players Pancreatic Cancer Therapy Market Share (2018-2019)
Table India Pancreatic Cancer Therapy Market Size by Type (2014-2019) (Million US$)
Table India Pancreatic Cancer Therapy Market Share by Type (2014-2019)
Table India Pancreatic Cancer Therapy Market Size by Application (2014-2019) (Million US$)
Table India Pancreatic Cancer Therapy Market Share by Application (2014-2019)
Figure Central & South America Pancreatic Cancer Therapy Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Pancreatic Cancer Therapy Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Pancreatic Cancer Therapy Market Share (2018-2019)
Table Central & South America Pancreatic Cancer Therapy Market Size by Type (2014-2019) (Million US$)
Table Central & South America Pancreatic Cancer Therapy Market Share by Type (2014-2019)
Table Central & South America Pancreatic Cancer Therapy Market Size by Application (2014-2019) (Million US$)
Table Central & South America Pancreatic Cancer Therapy Market Share by Application (2014-2019)
Table Eli Lilly Company Details
Table Eli Lilly Revenue in Pancreatic Cancer Therapy Business (2014-2019) (Million US$)
Figure Eli Lilly Revenue Growth Rate in Pancreatic Cancer Therapy Business (2014-2019)
Table Eli Lilly Recent Development
Table Roche Company Details
Table Roche Revenue in Pancreatic Cancer Therapy Business (2014-2019)(Million US$)
Figure Roche Revenue Growth Rate in Pancreatic Cancer Therapy Business (2014-2019)
Table Roche Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Pancreatic Cancer Therapy Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Pancreatic Cancer Therapy Business (2014-2019)
Table Pfizer Recent Development
Table Merck Company Details
Table Merck Revenue in Pancreatic Cancer Therapy Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Pancreatic Cancer Therapy Business (2014-2019)
Table Merck Recent Development
Table Celgene Company Details
Table Celgene Revenue in Pancreatic Cancer Therapy Business (2014-2019)(Million US$)
Figure Celgene Revenue Growth Rate in Pancreatic Cancer Therapy Business (2014-2019)
Table Celgene Recent Development
Table Novartis Company Details
Table Novartis Revenue in Pancreatic Cancer Therapy Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Pancreatic Cancer Therapy Business (2014-2019)
Table Novartis Recent Development
Table Amgen Company Details
Table Amgen Revenue in Pancreatic Cancer Therapy Business (2014-2019)(Million US$)
Figure Amgen Revenue Growth Rate in Pancreatic Cancer Therapy Business (2014-2019)
Table Amgen Recent Development
Table Teva Pharmaceutical Company Details
Table Teva Pharmaceutical Revenue in Pancreatic Cancer Therapy Business (2014-2019)(Million US$)
Figure Teva Pharmaceutical Revenue Growth Rate in Pancreatic Cancer Therapy Business (2014-2019)
Table Teva Pharmaceutical Recent Development
Table PharmaCyte Biotech Company Details
Table PharmaCyte Biotech Revenue in Pancreatic Cancer Therapy Business (2014-2019)(Million US$)
Figure PharmaCyte Biotech Revenue Growth Rate in Pancreatic Cancer Therapy Business (2014-2019)
Table PharmaCyte Biotech Recent Development
Table Clovis Oncology Company Details
Table Clovis Oncology Revenue in Pancreatic Cancer Therapy Business (2014-2019)(Million US$)
Figure Clovis Oncology Revenue Growth Rate in Pancreatic Cancer Therapy Business (2014-2019)
Table Clovis Oncology Recent Development
Table Global Pancreatic Cancer Therapy Market Size by Regions (Million US$) 2019-2025
Figure Global Pancreatic Cancer Therapy Market Size Share by Regions (2019-2025)
Figure Global Pancreatic Cancer Therapy Market Size Share by Regions in 2025
Figure United States Pancreatic Cancer Therapy Market Size Forecast (2019-2025)(Million USD)
Figure Europe Pancreatic Cancer Therapy Market Size Forecast (2019-2025)(Million USD)
Figure China Pancreatic Cancer Therapy Market Size Forecast (2019-2025)(Million USD)
Figure Japan Pancreatic Cancer Therapy Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Pancreatic Cancer Therapy Market Size Forecast (2019-2025)(Million USD)
Figure India Pancreatic Cancer Therapy Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Pancreatic Cancer Therapy Market Size Forecast (2019-2025)(Million USD)
Table Global Pancreatic Cancer Therapy Market Size by Product (2019-2025) (Million US$)
Figure Global Pancreatic Cancer Therapy Market Size by Product (2019-2025)
Figure Global Pancreatic Cancer Therapy Market Size by Product in 2025
Table Global Pancreatic Cancer Therapy Market Size by Application (2019-2025) (Million US$)
Figure Global Pancreatic Cancer Therapy Market Size by Application (2019-2025)
Figure Global Pancreatic Cancer Therapy Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
膵臓癌治療の世界市場：インサイト・予測 Pancreatic cancer arises when cells in the pancreas, a glandular organ behind the stomach, begin to multiply out of control and form a mass. These cancerous cells have the ability to invade other parts of the body.The global Pancreatic Cancer Treatment market is valued at xx million US$ in 2018 and …- 卵巣癌遺伝子治療の世界市場：市場規模・現状・予測 Ovarian cancer occurs and arises from several types of cells within the ovary, and it has the lowest survival rate of all gynecological cancers. Among many types, epithelial ovarian cancer (EOC) is the most common ovarian cancer, whereas ovarian low malignant potential tumor (OLMPT), germ cell tumor…
- がん遺伝子治療の世界市場：市場規模・現状・予測 Cancer could be defined as uncontrolled cell growth in the body leading to organ malfunction. If untreated, it can lead to death. Uncontrolled growth of cell is managed by the body in several ways, one of them is by deploying white blood cells to detect and eradicate these cancerous cells. It has be…
- 転移癌治療の世界市場：市場規模・現状・予測 Metastatic breast cancer is an advanced stage of breast cancer. It involves cases in which breast cancer has spread to the other parts of the body. Some of the most common organs which are affected by metastatic breast cancer are brain, liver, bones and lungs. It is also known as stage IV breast can…
- 外分泌膵機能不全の世界市場：市場規模・現状・予測 Exocrine pancreatic insufficiency (EPI) is an inability of proper digestion of food owing to insufficient levels of digestive enzymes from pancreas.EPI is commonly found in humans affected with Shwachman-Diamond Syndrome and cystic fibrosis. EPI is triggered by the progressive loss of pancreatic cel…